高榕创投

高榕创投

@gaorong

创造美好生活

499 articles

Articles

Pulmonary Hypertension Technology Developer Pulnovo Medical Raises Over 100 Million Yuan in Funding

China's first cardiovascular company in the pulmonary hypertension space to receive FDA Breakthrough Device designation.

高榕创投·

"Chaotianmen Dock" Closes Pre-A Round to Build Chongqing-Flavored New Consumer Brand

Bring authentic Chongqing flavor into every household.

高榕创投·

Rongbao · July | Multiple Companies Close New Funding Rounds, Take the Lead in Their Sectors; Pinduoduo's Olympic Season Boosts Sports Consumption for All

Continue to invest in innovative companies in new consumer brands, new technologies, healthcare, and other sectors.

高榕创投·

Yinjia Biotech Closes Pre-A Round, Advancing Its High-End Protein Platform to New Heights

Build a leading domestic "protein artisan" platform.

高榕创投·

XYZ Robotics Leads the Robotic Hand-Eye Coordination Race, Closes $35 Million Series B Round

Accelerating the arrival of fully autonomous perception and manipulation for robots.

高榕创投·

Cloud data management vendor eCloud Tech closes 100-million-yuan Series B round, redefining China's data backup market

A domestic leader in the CDM (Copy Data Management) space, providing enterprises with full-lifecycle data asset management.

高榕创投·

Adaps Photonics has released China's first dToF sensor built with 3D stacking technology, offering a groundbreaking solution for 3D sensing.

Overall performance reaches world-class standards.

高榕创投·

Kaikela Raises 600 Million RMB in Series B1 Funding to Accelerate Upgrades in Online Vocational Education

Kaikeba — making careers more flexible.

高榕创投·

Hygea Medical Completes Series C+ Round, Expanding Multi-Pipeline Portfolio in Minimally Invasive Tumor Interventional Therapy

Led by technologies such as the Cryoablation System, a new generation of minimally invasive tumor treatments is driving oncology toward procedures that are less invasive, more precise, and increasingly intelligent.

高榕创投·

Platonic Bio Closes Oversubscribed $55 Million Series A to Accelerate ADC Drug and Immuno-Oncology Platform Development

Enabling best-in-class and first-in-class ADCs to advance into clinical development.

高榕创投·

General AI Company Qiyuan World Completes 300 Million Yuan Series A Funding Round to Accelerate Buildout of AI Infrastructure for the Digital Age

Dedicated to creating great agent products, and bringing agents into every industry, every home, and every individual.

高榕创投·

Guoxin Technology Secures New Round of Strategic Investment to Lead Innovation in IoT AI Chips

Covering the full-scenario application of "human-vehicle-home," shaping a better life with "chips."

高榕创投·